These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6860730)

  • 1. Clinical response of aggressive schizophrenics to oral tryptophan.
    Morand C; Young SN; Ervin FR
    Biol Psychiatry; 1983 May; 18(5):575-8. PubMed ID: 6860730
    [No Abstract]   [Full Text] [Related]  

  • 2. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aggressiveness in schizophrenia: prevalence, psychopathological and sociodemographic correlates].
    Soyka M; Ufer S
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):171-7. PubMed ID: 11948430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of quetiapine on aggression and hostility in patients with schizophrenia.
    Arango C; Bernardo M
    Hum Psychopharmacol; 2005 Jun; 20(4):237-41. PubMed ID: 15830402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia.
    Strous RD; Ritsner MS; Adler S; Ratner Y; Maayan R; Kotler M; Lachman H; Weizman A
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):14-22. PubMed ID: 18824331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.
    Leiderman E; Zylberman I; Zukin SR; Cooper TB; Javitt DC
    Biol Psychiatry; 1996 Feb; 39(3):213-5. PubMed ID: 8837983
    [No Abstract]   [Full Text] [Related]  

  • 8. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population.
    Kim YR; Kim JH; Kim SJ; Lee D; Min SK
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):820-5. PubMed ID: 18789857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state.
    Jibiki I; Kubota T; Fujimoto K; Sakamoto H; Hasegawa M; Furuta H; Yamaguchi N
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878
    [No Abstract]   [Full Text] [Related]  

  • 10. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
    Bobes J; Fillat O; Arango C
    Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic treatment of schizophrenics at risk for violence.
    Soyka M
    Pharmacopsychiatry; 2001 Jan; 34(1):43-4. PubMed ID: 11229622
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
    Chaichan W
    J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial.
    Vinar O; Formánková M; Taussigová D; Růzicka S
    Act Nerv Super (Praha); 1967 Nov; 9(4):353-5. PubMed ID: 4889058
    [No Abstract]   [Full Text] [Related]  

  • 14. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive behavior model in schizophrenic patients.
    Song H; Min SK
    Psychiatry Res; 2009 May; 167(1-2):58-65. PubMed ID: 19359046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol monotherapy for treatment-resistant schizophrenia.
    Zuardi AW; Hallak JE; Dursun SM; Morais SL; Sanches RF; Musty RE; Crippa JA
    J Psychopharmacol; 2006 Sep; 20(5):683-6. PubMed ID: 16401651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the serotonin transporter gene (5-HTTLPR) and anger-related traits in Korean schizophrenic patients.
    Kim YR; Jahng JW; Min SK
    Neuropsychobiology; 2009; 59(3):165-71. PubMed ID: 19439997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine reduces violence and persistent aggression in schizophrenia.
    Glazer WM; Dickson RA
    J Clin Psychiatry; 1998; 59 Suppl 3():8-14. PubMed ID: 9541332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial use of risperidone in the treatment of acutely exacerbated schizophrenic patients--an interim analysis].
    Pajonk FG; Schreiner A; Peters S; Rettig K; Degner D; Rüther E
    Fortschr Neurol Psychiatr; 2003 May; 71(5):249-54. PubMed ID: 12740756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.